Russell B, Hawarden A, Gee M, Edmondson RJ, et al. Propensity score matching confirms that primary surgery or neoadjuvant chemotherapy result in equivalent survival within a comprehensive cohort of patients with high-grade serous ovarian cancer. Gynecol Oncol 2020 Nov 4. pii: S0090-8258(20)34057.
PMID: 33160693